Navigation Links
Omniscan™

ProductsOmniscan™
Company Amersham Health
Item Omniscan™
Features 
  • The leading nonionic MRI contrast medium
  • High-dose indication and rapid bolus injection rates
  • Proven safe and effective in both standard and cumulative triple-dose options (0.1 and 0.3 mmol/kg)
  • Low viscosity eases delivery with fine-gauge needles for rapid injections
  • Wide range of indications, including pediatric CNS and pediatric body
  • The clear choice for MRI imaging
  • Description OMNISCAN was launched in the U.S. in 1993 to provide contrast enhancement of the central nervous system (CNS) to detect lesions of the brain, spinal cord, and associated tissues. OMNISCAN has since received approval for adult body and high-dose CNS indications, and pediatric CNS and body indications. OMNISCAN comes in different sizes to accommodate the most commonly performed procedures, and it is also available in prefilled syringes and in Prefill Plus™, first needle-free device of its kind approved by the FDA for use in magnetic resonance imaging (MRI).
    Info Amersham Health
    Customer Service: (800) 654-0118
    Web site: http://www.amershamhealth-us.com/

    Related medicine products :

    1. Visipaque™
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products:
    (Date:4/18/2014)... researchers have been awarded two-year grants for their work ... month. Of the 110 initial submissions to the new ... only four projects were funded, three of which are ... M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, ... oncology, will use his $500,000 proof of principle grant ...
    (Date:4/18/2014)... Fraser University psychologists have made a brain-related discovery ... attention-deficit disorders. , This discovery opens up the ... or suppress a specific brain activity that the ... , The Journal of Neuroscience has ... John McDonald, an associate professor of psychology and ...
    (Date:4/18/2014)... by Northwestern Medicine scientists could lead to potential new ... people with scleroderma. , Fibrosis, or scarring, is ... the skin and lungs can lead to serious organ ... for new therapeutic options centers on findings made by ... identified the role that a specific protein plays in ...
    (Date:4/17/2014)... Scientists have identified the first genetic variant specifically ... sub-type accounting for around 10-15 per cent of ... study of the breast cancer sub-type, called invasive ... genetic causes of this particular kind of breast ... The research, published today (Thursday) in the journal ...
    (Date:4/17/2014)... study published today in PLOS Pathogens , children ... is common can mount an immune response to infection ... repeated bouts of high fever and illness and partially ... The findings may help researchers develop future interventions that ... parasite. , Each year, approximately 200 million cases of ...
    Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2
    ... ... ultrafiltration, NEW ... today that it will be exhibiting its Dual Stage,Ultrafilter products ... conference in Denver, Colorado, June,15th-19th, 2008. Building on the success ...
    ... BD (Becton,Dickinson and Company) (NYSE: BDX ), ... present at the Goldman Sachs Twenty-Ninth,Annual Global Healthcare Conference ... The live webcast of BD,s presentation can be accessed ... will be available for replay,through Wednesday, June 18, 2008., ...
    ... June 3 HLTH Corporation,(Nasdaq: HLTH ) ... definitive,agreement to sell its ViPS segment to General ... Dynamics Corporation,(NYSE: GD ) for $225 million ... conditions, including the expiration or termination of the ...
    ... can produce tiny magnetic nuggets after the introduction of ... gene MagA could become a valuable tool for tracking ... (MRI), says Xiaoping Hu, PhD, professor of biomedical engineering ... , "We have found a very simple way to ...
    ... N.Y., June 3 MedAmerica reports 2007 was ... results. In,addition, MedAmerica outperformed the long-term care insurance ... annual sales rate of 10%. (LIMRA 2007), ... Rochester, NY),MedAmerica Insurance Company (Home Office: Pittsburgh, PA), ...
    ... On June 7, 2008 the Philadelphia,Physicians for Student ... in the Philadelphia School District. Student,athletes in Pennsylvania ... eligible,to compete in interscholastic activities. The standard physicals ... enough to identify some potentially,life-threatening conditions., The ...
    Cached Medicine News:Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 2Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 3Health News:Nephros Exhibiting at Denver, Colorado APIC Conference June 15th-19th 4Health News:HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million 2Health News:HLTH Announces Agreement to Sell ViPS Unit to General Dynamics for $225 Million 3Health News:Philly's Top Doc's Organize to Help Prevent Young Athlete Deaths in Philadelphia 2
    (Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ...
    (Date:1/15/2014)... Jan. 15, 2014  A novel wearable injector slightly larger than ... for patients to self-inject prescription drugs in the large doses ... blood diseases, autoimmune deficiencies, and genetic disorders.  ... $220B by 2018, according to analysts.   Many of these drugs ...
    (Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
    Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3